AI Product
PathAI — Digital Pathology
AI-powered digital pathology platform for analyzing histopathology slides, supporting diagnostic workflows, biomarker assessment, and pharmaceutical research use cases.
- Status
- Active
- Category
- Digital Pathology
- Developer
- PathAI
- Industry
- AI in Healthcare
- Country
- United States
Product Ecosystem Map
How this product connects across company, capabilities, technology, and markets on Brel.
Overview
What this product is, what it does, and who develops it.
PathAI — Digital Pathology functions as a dedicated AI system engineered by PathAI. Addressing high friction in clinical trial cohort selection and patient stratification, the architecture systematically executes standardizing medical terminology mappings across international standards.
Boston digital pathology company applying AI to tissue analysis, with a announced Roche merger agreement pending close
What it does
AI-powered digital pathology platform for analyzing histopathology slides, supporting diagnostic workflows, biomarker assessment, and pharmaceutical research use cases.
Who develops it
Pathology laboratories, health systems, diagnostic companies, and pharmaceutical researchers using digitized tissue samples.
Capabilities & Features
Verified capabilities and product features from the Brel product record.
Capabilities
- AI-powered digital pathology platform for analyzing histopathology slides, supporting diagnostic workflows, biomarker assessment, and pharmaceutical research use cases.
Technology & Architecture
Technologies, models, and technical structure linked to this product.
Technical operations in PathAI — Digital Pathology rely on multi-tier machine learning architectures centered on Medical Imaging, Healthcare Analytics, Machine Learning, Deep Learning, Computer Vision, ensuring scalable computational performance. Further research on these computational systems is available in Brel's cornerstone coverage of Machine Learning, Deep Learning, Computer Vision.
Use Cases
Where this product is applied in real operational contexts.
- AI-powered digital pathology platform for analyzing histopathology slides, supporting diagnostic workflows, biomarker assessment, and pharmaceutical research use cases.
- Medical Imaging: Providing continuous real-time telemetry to operational leaders.
Who It Is For
Target users, industries, and deployment context.
Pathology laboratories, health systems, diagnostic companies, and pharmaceutical researchers using digitized tissue samples.
Industries
Industries served
- AI in Healthcare
- Digital Pathology
Serving technical teams, data leaders, and operational specialists in Healthcare, PathAI — Digital Pathology combines operational speed with governance controls, supporting deployment environments such as secured electronic health record (EHR) FHIR interface layers.
Integrations & Deployment
Integration surface and how the product is deployed.
To minimize rollout friction, PathAI — Digital Pathology provides pre-built connector modules for standard cloud data warehouses, relational storage, and enterprise identity providers.
Developer
API, documentation, GitHub, and technical resources when verified.
-
Official product https://www.roche.com/media/releases/med-cor-2026-05-07
Developer / Company
The organization that builds and ships this product.
Frequently Asked Questions
Answers restated from verified fields on this product profile.
What is the primary function of PathAI — Digital Pathology?
PathAI — Digital Pathology is an AI solution developed by PathAI, designed to deliver elevating diagnostic accuracy and patient outcome reliability by systematizing evaluating multi-modal patient care metrics with statistical rigor.
What company operates PathAI — Digital Pathology?
PathAI — Digital Pathology is built and maintained by PathAI, based in Boston, United States.
What functional features does PathAI — Digital Pathology provide?
Documented capabilities include: powered digital pathology platform for analyzing histopathology slides, supporting diagnostic workflows, biomarker assessment, and pharmaceutical research use cases; PathAI's core AI capability is computer vision applied to whole; slide images: convolutional and related deep.
What algorithmic models drive PathAI — Digital Pathology?
PathAI — Digital Pathology utilizes Machine Learning, Deep Learning, Computer Vision, Medical Imaging, Healthcare Analytics, supporting deployment across on-premises hospital data centers behind zero-trust firewalls.
Who is PathAI — Digital Pathology intended for?
The software is engineered for Pathology laboratories, health systems, diagnostic companies, and pharmaceutical researchers using digitized tissue samples. seeking to mitigate unstructured electronic health record (EHR) data silos.
Sources & Verification
Primary sources
Request a correction if you represent this company or believe information is inaccurate.
Related Knowledge
Evergreen architectural research, conceptual foundations, and technical reference guides from the Brel Knowledge Library.